Oncology

Areview of major clinical trials strongly supports the value of mammography screening for women in their 40s. The review showed a 24% decrease in deaths from breast cancer among women who underwent screening mammograms compared to

In clinical trials, screening mammography has been shown to reduce mortality from breast cancer by about 25% to 30% among women aged 50 years and older after only 5 to 6 years from the initiation of screening. Among women 40 to 49 years old, the evidence supporting the efficacy of screening mammography is less convincing.

his article discusses the costs and benefits of mammographic screening in the workplace. The cost of mammography itself and of diagnostic work-up are two of the largest costs involved.

The incidence of invasive breast cancer among women age 65 years or older is twice that among those age 35 to 44 years,

In the United States, efforts to reduce mortality from breast cancer focus primarily on secondary prevention (ie, early detection

Had Charles Darwin lived in the late 20th century, he might have found amusement in contemplating the evolution of biomedical journals.